Chronic Oral Selegiline Treatment Mitigates Age-Related Hearing Loss in BALB/c Mice. 2021

Judit Szepesy, and Viktória Humli, and János Farkas, and Ildikó Miklya, and Júlia Tímár, and Tamás Tábi, and Anita Gáborján, and Gábor Polony, and Ágnes Szirmai, and László Tamás, and László Köles, and Elek Sylvester Vizi, and Tibor Zelles
Department of Pharmacology and Pharmacotherapy, Semmelweis University, H-1089 Budapest, Hungary.

Age-related hearing loss (ARHL), a sensorineural hearing loss of multifactorial origin, increases its prevalence in aging societies. Besides hearing aids and cochlear implants, there is no FDA approved efficient pharmacotherapy to either cure or prevent ARHL. We hypothesized that selegiline, an antiparkinsonian drug, could be a promising candidate for the treatment due to its complex neuroprotective, antioxidant, antiapoptotic, and dopaminergic neurotransmission enhancing effects. We monitored by repeated Auditory Brainstem Response (ABR) measurements the effect of chronic per os selegiline administration on the hearing function in BALB/c and DBA/2J mice, which strains exhibit moderate and rapid progressive high frequency hearing loss, respectively. The treatments were started at 1 month of age and lasted until almost a year and 5 months of age, respectively. In BALB/c mice, 4 mg/kg selegiline significantly mitigated the progression of ARHL at higher frequencies. Used in a wide dose range (0.15-45 mg/kg), selegiline had no effect in DBA/2J mice. Our results suggest that selegiline can partially preserve the hearing in certain forms of ARHL by alleviating its development. It might also be otoprotective in other mammals or humans.

UI MeSH Term Description Entries
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008811 Mice, Inbred DBA An inbred strain of mouse. Specific substrains are used in a variety of areas of BIOMEDICAL RESEARCH such as DBA/1J, which is used as a model for RHEUMATOID ARTHRITIS. Mice, DBA,Mouse, DBA,Mouse, Inbred DBA,DBA Mice,DBA Mice, Inbred,DBA Mouse,DBA Mouse, Inbred,Inbred DBA Mice,Inbred DBA Mouse
D009435 Synaptic Transmission The communication from a NEURON to a target (neuron, muscle, or secretory cell) across a SYNAPSE. In chemical synaptic transmission, the presynaptic neuron releases a NEUROTRANSMITTER that diffuses across the synaptic cleft and binds to specific synaptic receptors, activating them. The activated receptors modulate specific ion channels and/or second-messenger systems in the postsynaptic cell. In electrical synaptic transmission, electrical signals are communicated as an ionic current flow across ELECTRICAL SYNAPSES. Neural Transmission,Neurotransmission,Transmission, Neural,Transmission, Synaptic
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006319 Hearing Loss, Sensorineural Hearing loss resulting from damage to the COCHLEA and the sensorineural elements which lie internally beyond the oval and round windows. These elements include the AUDITORY NERVE and its connections in the BRAINSTEM. Deafness Neurosensory,Deafness, Neurosensory,Deafness, Sensoryneural,Neurosensory Deafness,Sensorineural Hearing Loss,Sensoryneural Deafness,Cochlear Hearing Loss,Hearing Loss, Cochlear,Deafnesses, Neurosensory,Deafnesses, Sensoryneural,Neurosensory Deafnesses,Sensoryneural Deafness,Sensoryneural Deafnesses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000375 Aging The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. Senescence,Aging, Biological,Biological Aging
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Judit Szepesy, and Viktória Humli, and János Farkas, and Ildikó Miklya, and Júlia Tímár, and Tamás Tábi, and Anita Gáborján, and Gábor Polony, and Ágnes Szirmai, and László Tamás, and László Köles, and Elek Sylvester Vizi, and Tibor Zelles
July 2021, International journal of molecular sciences,
Judit Szepesy, and Viktória Humli, and János Farkas, and Ildikó Miklya, and Júlia Tímár, and Tamás Tábi, and Anita Gáborján, and Gábor Polony, and Ágnes Szirmai, and László Tamás, and László Köles, and Elek Sylvester Vizi, and Tibor Zelles
March 2018, Scientific reports,
Judit Szepesy, and Viktória Humli, and János Farkas, and Ildikó Miklya, and Júlia Tímár, and Tamás Tábi, and Anita Gáborján, and Gábor Polony, and Ágnes Szirmai, and László Tamás, and László Köles, and Elek Sylvester Vizi, and Tibor Zelles
August 2019, Cold Spring Harbor perspectives in medicine,
Judit Szepesy, and Viktória Humli, and János Farkas, and Ildikó Miklya, and Júlia Tímár, and Tamás Tábi, and Anita Gáborján, and Gábor Polony, and Ágnes Szirmai, and László Tamás, and László Köles, and Elek Sylvester Vizi, and Tibor Zelles
February 2017, Nursing older people,
Judit Szepesy, and Viktória Humli, and János Farkas, and Ildikó Miklya, and Júlia Tímár, and Tamás Tábi, and Anita Gáborján, and Gábor Polony, and Ágnes Szirmai, and László Tamás, and László Köles, and Elek Sylvester Vizi, and Tibor Zelles
June 1952, Wiener klinische Wochenschrift,
Judit Szepesy, and Viktória Humli, and János Farkas, and Ildikó Miklya, and Júlia Tímár, and Tamás Tábi, and Anita Gáborján, and Gábor Polony, and Ágnes Szirmai, and László Tamás, and László Köles, and Elek Sylvester Vizi, and Tibor Zelles
October 2007, Minnesota medicine,
Judit Szepesy, and Viktória Humli, and János Farkas, and Ildikó Miklya, and Júlia Tímár, and Tamás Tábi, and Anita Gáborján, and Gábor Polony, and Ágnes Szirmai, and László Tamás, and László Köles, and Elek Sylvester Vizi, and Tibor Zelles
April 2024, The New England journal of medicine,
Judit Szepesy, and Viktória Humli, and János Farkas, and Ildikó Miklya, and Júlia Tímár, and Tamás Tábi, and Anita Gáborján, and Gábor Polony, and Ágnes Szirmai, and László Tamás, and László Köles, and Elek Sylvester Vizi, and Tibor Zelles
November 1975, Journal of immunology (Baltimore, Md. : 1950),
Judit Szepesy, and Viktória Humli, and János Farkas, and Ildikó Miklya, and Júlia Tímár, and Tamás Tábi, and Anita Gáborján, and Gábor Polony, and Ágnes Szirmai, and László Tamás, and László Köles, and Elek Sylvester Vizi, and Tibor Zelles
February 2004, Hearing research,
Judit Szepesy, and Viktória Humli, and János Farkas, and Ildikó Miklya, and Júlia Tímár, and Tamás Tábi, and Anita Gáborján, and Gábor Polony, and Ágnes Szirmai, and László Tamás, and László Köles, and Elek Sylvester Vizi, and Tibor Zelles
November 2016, Scientific reports,
Copied contents to your clipboard!